Ultrasensitive particles offer new way to find cancer
Tiny particles that measure microRNA levels in tissue samples could help diagnose and monitor many diseases.
Tumor cells go against the flow
Microfluidic model helps explain how fluid’s flow in bodily tissue influences tumor cell migration.
New lung cancer gene found
Cancer biologists identify a driving force behind the spread of an aggressive type of lung cancer.
Study explains why men are at higher risk for stomach cancer
MIT researchers show how estrogen protects women from the gastric inflammation that can lead to cancer.
Biologists discover how yeast cells reverse aging
The gene they found can double yeast lifespan when turned on late in life.
Working in harmony
MIT-designed nanoparticles communicate with each other inside the body to target tumors more efficiently.'
Turning off cancer’s growth signals
Biological engineers’ new approach to shutting down cell division could lead to new cancer drugs.
Removable ‘cloak’ for nanoparticles helps them target tumors
New MIT particles could be used to deliver cancer drugs to nearly any type of tumor.
Understanding why lung cancer spreads
MIT biologists pinpoint a genetic change that helps tumors move to other parts of the body.
Catching cancer with carbon nanotubes
New device to test blood can spot cancer cells, HIV on the fly
In vivo systems biology
Using computer models, systems biologists can predict complicated behavior of cells in living animals
The past, present and future of cancer
Researchers gather to discuss the state of their field and the potential for new treatments.
David H. Koch Institute for Integrative Cancer Research feted
MIT celebrates the official opening of the institute's new building.
Going with the flow
New 3-D microfluidic system offers greater control over production of drug-delivering nanoparticles.
Exploiting cancer cells' weaknesses
Team identifies potential drugs that enhance stress caused by too many chromosomes.